Oxy-Powder® - Clinical Studies - Summary - IBS (Irritable Bowel Syndrome)
www.oxypowder.com
updated 4 months ago
This summary report has been extracted from the Original Phase I, II, and III active, controlled Clinical Studies on Oxy-Powder®. We tested many components of Oxy-Powder® including acute toxicity, sub-chronic toxicity and anti-bacterial activity. We also tested the effectiveness of Oxy-Powder® for symptoms of chronic constipation, and IBS (Irritable Bowel Syndrome). For ease of reading, we summarized the results of each test.
Summary of Oxy-Powder® Clinical Study Results for IBS with related constipation.
- None (0%) of the IBS test patients reported any Adverse Reactions to Oxy-Powder® after 6 weeks of use.
- 27 out of 27 (100%) of the IBS test patients had Straining during their Bowel Movements on Day 0 of testing as compared to only 1 of the patients on Day 42.
- 24 out of 27 patients (92.3%) suffering from IBS indicated that Oxy-Powder® was successful in relieving straining during bowel movements.
- 24 out of 27 (92.3%) of the IBS test patients passed hard and lumpy stools during bowel movements on Day 0 whereas on Day 21 and through day 42, none (0%) of the patients passed hard and lumpy stools. This indicated a 100% success rate for Oxy-Powder® in relieving symptoms of hard and lumpy stools within 21 days.
- 27 out of 27 (100%) of the IBS test patients had Sensation of Incomplete Evacuation during their bowel movements on Day 0 of testing, which was reduced to only 6 out of 27 (23.1%) of the patients on Day 42.
- 20 out of 27 (76.9%) patients suffering from IBS indicated that Oxy-Powder® was successful in relieving sensations of incomplete evacuation during bowel movements.
- 10 out of 27 (38.5%) of the IBS test patients had Sensation of Anorectic Blockage during bowel movements on Day 0 whereas on Day 21 and through day 42, none of the patients (0%) had sensation of anorectic blockage. This indicated a 100% success rate for Oxy-Powder® in relieving sensations of anorectic blockage within 21 days in patients suffering from IBS.
- 10 out of 27 (30.8%) IBS test patients had to perform Manual Maneuvers to Facilitate their Bowel Movements on Day 0 whereas on Day 21 and through day 42, none (0%) of the patients had to perform manual maneuvers. This indicated a 100% success rate for Oxy-Powder® in relieving manual maneuvers to facilitate bowel movements within 21 days.
- 20 out of 27 (76.9%) IBS test patients had Abdominal Pain associated with a change in frequency of Stools on Day 0. On Day 21, only 4 out of 27 (15.4%) patients had abdominal pain and on Day 42, none of the (0%) patients had Abdominal Pain associated with a change in frequency of stools. This indicated a 100% success rate for Oxy-Powder® in relieving abdominal pain associated with a change in frequency of stools after 42 days.
- 14 out of 27 (53.8%) of the IBS test patients had Abdominal Pain associated with a change in form of stools on Day 0. On Day 21, only 2 out of 27 (7.7%) patients had abdominal pain and on Day 42, none of the patients (0%) patients had abdominal pain associated with a change in form of stools. This indicated a 100% success rate for Oxy-Powder® in relieving abdominal pain associated with a change in form of stools after 42 days.
- 6 out of 27 (23.1%) of the IBS test patients Passed Mucous during their Bowel Movement on Day 0, where as by Day 21 and continuing through Day 42, none (0%) of the patients passed mucous during their bowel movement. This indicated a 100% success rate for Oxy-Powder® in relieving mucous during bowel movements within 21 days.
- 22 out of 27 (84.6%) of the IBS test patients had Abdominal Fullness (bloating) on day 0. On Day 21, only 8 out of 27 (30.8%) of the patients had abdominal fullness and on Day 42, only 2 out of 27 (7.7%) of the patients had abdominal fullness (bloating).
- 24 out of 27 (92.3%) indicated that Oxy-Powder® was successful in relieving abdominal fullness (bloating) within 42 days.
- 8 out of 27 (30.8%) of the patients treated with Oxy-Powder® reported a Complete Cure for IBS with related constipation after 6 weeks of testing.
- 18 out of 27 (69.2%) of the patients treated with Oxy-Powder® reported significant Improvement in symptoms of IBS with related constipation after 6 weeks.
- None of the patients (0%) treated with Oxy-Powder® reported failure in treating IBS with Related Constipation after 6 weeks.
"Safety and Efficacy of Oxy-Powder® in treating IBS with constipation was significantly high, thus indicating Oxy-Powder® was both safe and efficacious in treating patients of IBS with constipation".
NOTE: This trial was restricted to 42 days (6 weeks) to get a success rate of safety and efficacy in an optimum period of use. Individuals are at liberty to modify the duration and dosing as per the guidance of their physician. This is due to the high levels of safety of Oxy-Powder®, experimentally determined in animal toxicity testing in rats as per OECD regulatory guidelines as well as in Patients suffering from IBS with Constipation.
"The clinical trial has been conducted following Globally accepted Regulatory Guidelines and practices as follows":
- Human clinical trial was conducted following "Good Clinical Practices (GCP)" under supervision of an expert team following Helsinki's Declaration for protection of rights of the patients.The entire study was conducted based on globally accepted ICH 6E guidelines for determining Safety, Efficacy and Tolerability of Oxy-Powder® in Human subjects.
- The Animal toxicity studies were conducted in an ISO certified laboratory following WHO GCP guidelines and as per OECD tests.
- The capsules can be safely consumed by all vegetarians and non-vegetarians alike The ingredients, including the outer inactive cover (Kosher Shell) are Vegetarian. None of the non-vegetarian materials such as gelatin, egg product, meat or chicken products, sea food products, non-vegetarian oils and fats have been employed in the formulation or during processing.
